Doximity's stock is sinking on conservative guidance, but its long-term investment thesis remains intact.

Doximity’s (NASDAQ:DOCS) defence rests on trusted clinician identity, ease of use, and workflow familiarity. The challenge is maintaining differentiation as comparable features spread and as buyers ...

Doximity’s fourth quarter results for 2025 were met with a sharp negative market reaction, as management cited a combination ...

Doximity (DOCS) has drawn fresh attention after a sharp pullback, with the stock showing declines over the past week, month and past 3 months, while the business continues to report revenue and net ...

Doximity, a networking platform for healthcare professionals, has entered into an agreement to acquire on-call physician scheduling and messaging app Amion. According to a filing with the Securities ...

Doctors on the industry networking site Doximity are finding their news feed inundated with anti-vaccine comments from fellow physicians. "You rarely get to the level of microchips in vaccines, but a ...